Hyundai Bioscience Co., Ltd. announced a private placement of series 9 unsecured convertible private placement convertible bonds for the gross proceeds of KRW 18,000,000,000 on May 16, 2024. The bonds will have a coupon rate of 2% and maturity rate of 7%. The bonds will be convertible into 858,655 common shares at a price of KRW 20,963.

The bonds will be matured on May 20, 2072. The transaction will include participation from new investor, Sangsangin Investment & Securities Co.,Ltd. for KRW 1,000,000,000, Sangsangin Plus Savings Bank Co.,Ltd. for KRW 5,000,000,000, Sangsangin Savings Bank for KRW 12,000,000,000. The transaction has been approved by the shareholders of the company and is expected to close on May 20, 2024.